Among the companies whose shares are expected to actively trade in Tuesday's session are Best Buy Co. (BBY), Urban Outfitters Inc. (URBN) and Ivanhoe Mines Ltd. (IVN, IVN.T).
Strong mobile-device sales at Best Buy were again overshadowed by declining demand for TVs and other consumer electronics and entertainment gadgets. Best Buy's computing and mobile domestic sales increased 8.8% on a comparable basis in the fiscal third quarter, but the product type was the only one except the nascent appliance category to report such growth. Shares tumbled 9.1% to $25.51 in recent premarket trading on the miss.
Urban Outfitters said the fourth-quarter same-store sales in its retail segment are tracking up in the mid single-digit percent, higher than analysts were projecting. The Philadelphia-based retailer provided the fourth-quarter update in a regulatory filing with the Securities and Exchange Commission. Shares gained 12% to $29.65 in recent premarket trading.
Rio Tinto PLC (RIO) said it reserves the right to increase its stake in Canadian mining concern Ivanhoe Mines Ltd., but doesn't have any plans to make a full takeover offer after winning an arbitration process involving Ivanhoe. The Anglo-Australian miner has been successful in its challenge to protect its rights against a poison pill defense adopted by Ivanhoe; Rio will be able to maintain its 49% stake if any bid for Ivanhoe triggers the smaller company's shareholder rights plan adopted last year, Ivanhoe said in a statement. Rio Tinto's shares climbed 2.1% to $50.14 in recent premarket trading, while Ivanhoe slumped 14% to $17.85.
DuPont Co. (DD) offered a forecast for earnings next year that came in mostly above analyst expectations, signaling hope for the manufacturing sector's prospects in the coming year.
Alexza Pharmaceuticals Inc. (ALXA) said a U.S. Food and Drug Administration panel has recommended that its schizophrenic and bipolar disorder treatment be approved for use. Shares surged 68% to $1.05 in recent premarket trading.
FuelCell Energy Inc.'s (FCEL) fiscal fourth-quarter loss narrowed as margins and backlog swelled, driven by new orders of its large-scale power plant units. The results were stronger than analysts expected. Shares climbed 0.9% to $1.10 in recent premarket trading.
Pantry Inc.'s (PTRY) fiscal fourth-quarter earnings sank 61% as the Southeastern convenience-store and gasoline-station operator saw lower same-store gasoline and merchandise sales. Shares fell 6.6% to $11.09 in recent premarket trading.
Primerica Inc. (PRI) said former parent Citigroup Inc. (C) is selling its remaining eight million shares in the life-insurance business. Further terms weren't disclosed. At Monday's close, the stake is valued at about $186 million.
Royale Energy Inc. (ROYL) said it had acquired more than 100,000 acres in the "heart of the oil window" during the state of Alaska's North Slope lease sale. "This acquisition has the potential of being a continuous accumulation of oil produced from shale," said Donald Hosmer, Royale's co-CEO, "providing a large number of repeatable drilling opportunities that can lead to significant and extended reserve growth for Royale Energy." Shares climbed 5.6% to $5.27 in recent premarket trading.
Booz Allen Hamilton Corp. (BAH) said its board has approved a $30 million share-repurchase program, to be funded with cash on hand, as the consulting company looks to boost shareholder value.
Cabot Microelectronics Corp.'s (CCMP) board agreed to provide a $15-a-share special dividend funded by cash on hand and new debt and boosted its share repurchase program, in an effort to buoy shareholder value.
Cosi Inc. (COSI) named Brinker International Inc. (EAT) executive Carin L. Stutz as the casual dining chain's new chief executive and president, effective Jan. 1, concluding the company's search for a permanent CEO. Stutz, who has worked at a number of restaurant companies, will also join the board of directors, the company said.
Cypress Semiconductor Corp. (CY) said rival Avago Technologies Inc. (AVGO) has ended a patent-infringement lawsuit against it. Cypress said it didn't pay damages or admit to any infringement in the case.
FactSet Research Systems Inc.'s (FDS) fiscal first-quarter earnings rose 9.4%, helped by higher revenue and client growth, though recent volatility in financial markets interrupted buying patterns from some clients. The financial software company projected per-share earnings above analysts' consensus view for the current quarter, but revenue outlook fell slightly below Street estimates.
Railroad operator Genesee & Wyoming Inc.'s (GWR) November traffic rose 9.7% from a year earlier, helped by recent acquisitions and an increase in metals shipments.
Johnson & Johnson (JNJ) said Monday it will release new batches of cancer drug oxil, which has been in short supply this year due to problems at a contract manufacturer.
Magellan Health Services Inc. (MGLN) unveiled 2012 guidance and a new senior secured revolving credit facility of $230 million. The manager of behavioral health care, diagnostic imaging and other health-care services forecast overall earnings that fell beneath Wall Street's expectations, though the revenue outlook exceeded analysts' consensus view.
MarkWest Energy Partners LP (MWE) unveiled a public offering of its units to fund a proposed acquisition, while Pioneer Natural Resources Co. (PXD) and Pioneer Southwest Energy Partners LP (PSE) said they will both offer units to raise money for general corporate purposes.
Medtronic Inc. (MDT) has agreed to pay $23.5 million to resolve allegations that it paid illegal kickbacks to physicians who participated in its post-market studies and device registries to induce doctors to implant the company's pacemakers and defibrillators, the Department of Justice said Monday.
Standard & Poor's Ratings Services put MEMC Electronic Materials Inc.'s (WFR) junk-grade credit status on watch for possible downgrade, citing a litany of risks from the company's exposure to the oversupplied solar-energy sector.
Neoprobe Corp. (NEOP) said it has gained exclusive worldwide licensing rights for a radioimaging material from AstraZeneca PLC (AZN, AZN.LN) that might help better diagnose Alzheimer's disease.
Oil-and-gas exploration and production company Penn Virginia Corp. (PVA) lowered its production guidance for its fourth quarter, citing the timing of its Eagle Ford Shale projects and a revised method for estimating production from Eagle Ford wells.
Pilgrim's Pride Corp. (PPC) extended the deadline for an exchange offer for $500 million worth of its senior notes. The poultry processor last month launched an offer to swap senior notes due in 2018 for exchange notes that are substantially identical to the outstanding notes, except that the exchange notes don't have any transfer restrictions and aren't entitled to any registration rights, among other provisions.
Range Resources Corp. (RRC) selected company insider Ray Walker as its new chief operating officer, continuing a series of management changes unveiled by the natural-gas company earlier this year.
Sensata Technologies Holding N.V. (ST) cut its fourth-quarter adjusted earnings and revenue predictions, primarily due to the impact of the flooding in Thailand on the company's sensors business, lower production levels and a reduction in inventories throughout the automotive supply chain. The company noted the floods haven't had a material impact on its supply chain, but it has negatively affected production schedules for certain automotive original equipment manufacturers.
Southwest Airlines Co. (LUV) confirmed plans to order 150 of Boeing Co.'s (BA) planned 737 Max jetliners, making the airline the first customer to finalize an order for the more fuel-efficient aircraft.
Spartech Corp.'s (SEH) fiscal fourth-quarter loss narrowed as the packaging company again increased selling prices to pass through higher raw material costs and offered a greater mix of higher-priced products, though margins continued to fall.
Warner Chilcott PLC (WCRX) said a federal appeals court vacated a lower court's ruling that had prevented Mylan Inc. (MYL) from releasing a generic version of its Doryx acne drug until pending patent litigation was decided.
-Edited by Ian Thomson and Corrie Driebusch; write to firstname.lastname@example.org and email@example.com